Genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the only approach to rapidly monitor and tackle emerging variants of concern (VOC) of the COVID-19 pandemic. Such scrutiny is crucial to limit the spread of VOC that might escape the immune protection conferred by vaccination strategies or previous virus exposure. It is also becoming clear now that efficient genomic surveillance would require monitoring of the host gene expression to identify prognostic biomarkers of treatment efficacy and disease progression. Here we propose an integrative workflow to both generate thousands of SARS-CoV-2 genome sequences per week and analyze host gene expression upon infection.

Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients / Grimaldi, Antonio; Panariello, Francesco; Annunziata, Patrizia; Giuliano, Teresa; Daniele, Michela; Pierri, Biancamaria; Colantuono, Chiara; Salvi, Marcello; Bouché, Valentina; Manfredi, Anna; Cuomo, Maria Concetta; Di Concilio, Denise; Tiberio, Claudia; Fiorenza, Mariano; Portella, Giuseppe; Cimmino, Ilaria; Sorrentino, Antonio; Fusco, Giovanna; Granata, Maria Rosaria; Cerino, Pellegrino; Limone, Antonio; Atripaldi, Luigi; Ballabio, Andrea; Cacchiarelli, Davide. - In: GENOME MEDICINE. - ISSN 1756-994X. - 14:1(2022), p. 90. [10.1186/s13073-022-01098-8]

Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients

Grimaldi, Antonio;Panariello, Francesco;Salvi, Marcello;Portella, Giuseppe;Cerino, Pellegrino;Ballabio, Andrea
;
Cacchiarelli, Davide
Ultimo
2022

Abstract

Genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the only approach to rapidly monitor and tackle emerging variants of concern (VOC) of the COVID-19 pandemic. Such scrutiny is crucial to limit the spread of VOC that might escape the immune protection conferred by vaccination strategies or previous virus exposure. It is also becoming clear now that efficient genomic surveillance would require monitoring of the host gene expression to identify prognostic biomarkers of treatment efficacy and disease progression. Here we propose an integrative workflow to both generate thousands of SARS-CoV-2 genome sequences per week and analyze host gene expression upon infection.
2022
Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients / Grimaldi, Antonio; Panariello, Francesco; Annunziata, Patrizia; Giuliano, Teresa; Daniele, Michela; Pierri, Biancamaria; Colantuono, Chiara; Salvi, Marcello; Bouché, Valentina; Manfredi, Anna; Cuomo, Maria Concetta; Di Concilio, Denise; Tiberio, Claudia; Fiorenza, Mariano; Portella, Giuseppe; Cimmino, Ilaria; Sorrentino, Antonio; Fusco, Giovanna; Granata, Maria Rosaria; Cerino, Pellegrino; Limone, Antonio; Atripaldi, Luigi; Ballabio, Andrea; Cacchiarelli, Davide. - In: GENOME MEDICINE. - ISSN 1756-994X. - 14:1(2022), p. 90. [10.1186/s13073-022-01098-8]
File in questo prodotto:
File Dimensione Formato  
13073_2022_Article_1098.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Dominio pubblico
Dimensione 417.63 kB
Formato Adobe PDF
417.63 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/892745
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 12
social impact